| 000 | 00999 a2200265 4500 | ||
|---|---|---|---|
| 005 | 20250513092933.0 | ||
| 264 | 0 | _c19960905 | |
| 008 | 199609s 0 0 eng d | ||
| 022 | _a0171-5216 | ||
| 024 | 7 |
_a10.1007/BF01187154 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMarkman, M | |
| 245 | 0 | 0 |
_aCarboplatin and cisplatin: are they equivalent in efficacy in "optimal residual" advanced ovarian cancer? _h[electronic resource] |
| 260 |
_bJournal of cancer research and clinical oncology _c1996 |
||
| 300 |
_a443-4 p. _bdigital |
||
| 500 | _aPublication Type: Editorial | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aCarboplatin _xtherapeutic use |
| 650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xdrug therapy |
| 773 | 0 |
_tJournal of cancer research and clinical oncology _gvol. 122 _gno. 8 _gp. 443-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/BF01187154 _zAvailable from publisher's website |
| 999 |
_c8696028 _d8696028 |
||